Dasatinib-induced follicular lymphoid hyperplasia, an entity to know

被引：0

作者：

Phelippeau, Mona ^{[1
]}

Lefebvre, Christine ^{[2
]}

Jacob, Marie-Christine ^{[3
]}

Syrykh, Charlotte ^{[4
]}

Ghelfi, Julien ^{[5
]}

Carras, Sylvain ^{[2
,6
,7
]}

Laurent, Camille ^{[4
]}

Molina, Lysiane ^{[7
]}

Valmary-Degano, Severine ^{[1
,6
]}

机构：

[1] CHU Grenoble Alpes, Serv Anat & Cytol Pathol, F-38000 Grenoble, France

[2] CHU Grenoble Alpes, Lab Hematol, F-38000 Grenoble, France

[3] CHU Grenoble Alpes, Lab Immunol, F-38000 Grenoble, France

[4] Inst Univ Canc Toulouse, Toulouse Oncopole, Serv Anat & Cytol pathol, F-31000 Toulouse, France

[5] CHU Grenoble Alpes, Dept Radiol, F-38000 Grenoble, France

[6] Univ Grenoble Alpes, Inst avancee Biosci IAB, Inserm U1209, CNRS UMR5309, F-38000 Grenoble, France

[7] Ctr Hosp Univ Grenoble Alpes, Serv dhematol, F-38000 Grenoble, France

来源：

ANNALES DE PATHOLOGIE | 2023年 / 43卷 / 01期

关键词：

Follicular lymphoid hyperplasia; Dasatinib; Side effects; Drug induced lymphadenopathy; TYROSINE KINASE INHIBITOR; LEUKEMIA;

D O I：

10.1016/j.annpat.2022.09.005

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Follicular lymphoid hyperplasia induced by dasatinib is an entity recently described. It is sometimes difficult to rule out the diagnostic of small B-cell lymphoma. Usually, the node is swollen, with follicular architecture conserved, composed by germinal centers with variable size and shape, with a hight number of mitoses and tingible bodies macrophages inside. Follicular lymphoid hyperplasia is isolated or associated with multiple reactive patterns. The immunohistochemical profil of germinal centers is CD20+, CD10+, BCL6+, BCL2-. Swollen node disappears in a short time after dasatinib discontinuation. Clinicians and pathologists need to be aware of this entity, so as not to avoid mistakenly suspect lymphoma when lymphadenopathy occurs in a patient with chronic myeloid leukemia treated with dasatinib. (c) 2022 Elsevier Masson SAS. All rights reserved.

引用

页码：45 / 51

页数：7

共 50 条

[1] Follicular lymphoid hyperplasia: a rare adverse effect of dasatinib
Bouquet, E.
Jourdain, A.
Machet, M. C.
Beau-Salinas, F.
Jonville-Bera, A. P.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 62 - 62
[2] DASATINIB-INDUCED CHYLOTHORAX
Jasti, V.
Willett, A.
Anderson, J.
CHEST, 2022, 161 (06) : 579A - 579A
[3] Dasatinib-induced lupus
Rea, Delphine
Bergeron, Anne
Fieschi, Claire
Bengoufa, Djaouida
Oksenhendler, Eric
Dombret, Herve
LANCET, 2008, 372 (9640): : 713 - 714
[4] Dasatinib-induced Colitis
Wubiee, Firew
Dagne, Rekik
Kibreab, Angesom
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1534 - S1534
[5] Dasatinib-related Follicular Hyperplasia An Underrecognized Entity With Characteristic Morphology
Ozawa, Michael G.
Ewalt, Mark D.
Gratzinger, Dita
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (10) : 1363 - 1369
[6] Dasatinib-induced acute hepatitis
Bonvin, A.
Mesnil, A.
Nicolini, F. E.
Cotte, L.
Michallet, M.
Descotes, J.
Vial, T.
LEUKEMIA & LYMPHOMA, 2008, 49 (08) : 1630 - 1632
[7] Dasatinib-induced platelet dysfunction
Quinitas-Cardama, Alfonso
Han, Xin
Kantarjian, Hagop
Cortes, Jorge
BLOOD, 2007, 110 (11) : 864A - 864A
[8] RECURRENT DASATINIB-INDUCED CHYLOTHORAX
Dalbah, Rami
Alkharabsheh, Murad
Al-Khateeb, Mohannad
Fahmawi, Suhib S. F.
CHEST, 2022, 162 (04) : 1426A - 1426A
[9] Dasatinib-induced loss of eyebrows
Naithani, Rahul
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (03) : 362 - 362
[10] Dasatinib-induced nephrotic syndrome
Hirano, Taichi
Hashimoto, Miyuki
Korogi, Yu
Tsuji, Takahiro
Miyanaka, Kei
Yamasaki, Hiroshi
Tsuda, Hiroyuki
LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 726 - 727

← 1 2 3 4 5 →